Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Governments and health authorities are increasingly recognizing the importance of GLP-1 therapies in managing chronic diseases, leading to expedited approval processes for new drugs
A synthetic 31-amino acid C18 fatty diacid-conjugated GLP-1 analogue and the most extensively characterised long-acting selective glucagon-like peptide-1 receptor agonist research compound available to laboratories in Ireland and a structurally optimised GLP-1(7-37) analogue incorporating Aib8 substitution for DPP-IV resistance, Arg34Lys substitution eliminating a proteolytic site, and a C18 fatty diacid conjugated via a hydrophilic linker to Lys26 enabling tight reversible albumin binding that produces a circulating half-life of about one week and once-weekly pharmacokinetics activating the GLP-1 receptor through canonical Gs-cAMP-PKA-EPAC2 signal transduction in pancreatic beta cells, hypothalamic appetite-regulating nuclei, brainstem nucleus tractus solitarius, cardiac tissue, and peripheral organs to produce glucose-stimulated insulin secretion potentiation, glucagon suppression, gastric emptying inhibition, pronounced central appetite suppression and body weight reduction, beta cell trophic biology, and cardioprotective signalling
doi:10.1371/journal.pone.0131122 eCollection 2015
Your monthly cost covers the medication, shipping, supplies, and unlimited provider messaging
Nausea typically peaks during the first week and gradually subsides as your body establishes a new baseline
Potential Side Effects And Risks Visualizing the potential side effects and risks associated with testosterone replacement therapy injections is essential to ensure patient safety and adherence to treatment
